Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ARF function does not require p53 stabilization or Mdm2 relocalization.

Chandrashekhar Korgaonkar1, Lili Zhao, Modestos Modestou

  • 1Department of Pharmacology. Molecular Biology Graduate Program, University of Iowa College of Medicine, Iowa City, Iowa 52242, USA.

Molecular and Cellular Biology
|December 12, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intratumoral plasma cells mediate CD8+ T cell infiltration and successful immune checkpoint blockade therapy in <i>de novo</i> MPNSTs.

bioRxiv : the preprint server for biology·2026
Same author

Variable GLP-1 receptor expression across diverse neuroendocrine neoplasms: implications for incretin therapies.

Endocrine oncology (Bristol, England)·2025
Same author

Novel Therapeutics and the Path Toward Effective Immunotherapy in Malignant Peripheral Nerve Sheath Tumors.

Cancers·2025
Same author

Histone Deacetylase Inhibitors Target DNA Replication Regulators and Replication Stress in Ewing Sarcoma Cells.

Cancer research communications·2025
Same author

Risk Factors Associated with Gastroenteropancreatic and Lung Neuroendocrine Tumors: A Nested Case-Control Study from the All of Us Research Program.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2025
Same author

NET Models Meeting 2024 white paper: the current state of neuroendocrine tumour research models and our future aspirations.

Endocrine oncology (Bristol, England)·2025
Same journal

Transcription Factors in Breast Cancer Oncogenesis and Progression.

Molecular and cellular biology·2026
Same journal

Aberrant Expression of miR-25-3p/EZH2 Is Involved in T Cell Activation in Aplastic Anemia.

Molecular and cellular biology·2026
Same journal

Characterization of the m<sup>6</sup>A Epitranscriptome in Fibroblast Senescence.

Molecular and cellular biology·2026
Same journal

Insights into FACT in Cancers with Targeted Therapeutic Implications.

Molecular and cellular biology·2026
Same journal

Human lncRNA, hLinfRNA7 (IDO1-AS) Regulates Cytokine Expression, Tryptophan Catabolism, and Inflammatory Response in Macrophage.

Molecular and cellular biology·2026
Same journal

mTORC1-Dependent Regulation of the CCL24-CCR3 Axis Controls Granuloma Formation and Maintenance in Sarcoidosis.

Molecular and cellular biology·2026
See all related articles

The ARF tumor suppressor

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • The ARF tumor suppressor is known to induce p53-dependent growth arrest by sequestering Mdm2 in the nucleolus.
  • Previous studies identified residues 1-14 and 26-37 of murine ARF as critical for Mdm2 binding and nucleolar localization.

Purpose of the Study:

  • To investigate the specific roles of ARF residues in Mdm2 binding, nucleolar localization, and p53-dependent and -independent growth arrest.
  • To determine if p53 stabilization is essential for ARF-mediated p53 transcriptional activation.
  • To explore the relationship between ARF's growth-suppressive activity and Mdm2 relocalization.

Main Methods:

  • Site-directed mutagenesis of mouse ARF to create deletion mutants.
  • Assays for ARF-induced growth arrest, p53 stabilization, and p53 transcriptional activation.

Related Experiment Videos

  • Analysis of ARF nucleolar localization and Mdm2 import in p53-positive and p53/Mdm2-null cells.

    • Main Results:

    • ARF residues 6-10 and 21-25 are crucial for ARF-induced growth arrest, while residues 1-5 and 29-34 are not.
    • Mutants D1-5 and D29-34 induced p53 transcriptional activation without stabilizing p53, and retained p53-independent growth arrest.
    • Mutants lacking residues 6-10 or 21-25 failed to suppress growth in p53-positive cells despite nucleolar localization and Mdm2 import.

    Conclusions:

    • p53 stabilization is not required for ARF-mediated p53 transcriptional activation.
    • ARF exhibits p53-independent growth-suppressive functions.
    • ARF activity is not directly correlated with Mdm2 relocalization, indicating other mechanisms are involved in ARF tumor suppression.